All In MedTech

Device Trial Radar · NCT06866418

Phagenyx® Registry Study

Phagenyx® Registry Study: Evaluating Swallowing Therapy Outcomes and Recovery in the U.S.

Last checked: Nov 19, 2026Latest source record: Jul 9, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

600

Planned (sponsor's estimate)

Start

Sep 15, 2025

Primary completion

Sep 2035

Study completion Sep 2036

Sponsor

Lead sponsor
Phagenesis Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Mar 10, 2025

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A retrospective, open-label, matched-control registry study designed to characterize the effectiveness of Pharyngeal Electrical Stimulation (PES) to improve swallowing in patients with severe dysphagia post stroke when delivered using the Phagenyx® System in real-world clinical settings in hospitals in the United States of America (US).

Conditions

  • Dysphagia

Interventions

  • 1. Phagenyx® System Group PatientsDevice

    Patients who have undergone Pharyngeal Electrical Stimulation (PES) treatment for severe dysphagia using the Phagenyx® System

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Swallowing safetyTime frame: Baseline to 2 (+1 days) post final PES treatment (Approximately 6 days).
  2. Nutritional ManagementTime frame: Baseline to Hospital Discharge (up to approximately 30 days)

Locations

3 sites in 1 country. Site status is shown where the registry gives one.

  • Banner University Medical Center

    Phoenix, Arizona · Recruiting

  • HMH Jersey Shore University Medical Center

    Neptune City, New Jersey · Recruiting

  • University of Texas

    Houston, Texas · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.